- Home
- AEON vs ZBAI Comparison
AEON vs ZBAI Comparison
Compare AEON & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- ZBAI
- Stock Information
- Founded
- AEON N/A
- ZBAI 2015
- Country
- AEON United States
- ZBAI United States
- Employees
- AEON N/A
- ZBAI N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- ZBAI Professional Services
- Sector
- AEON Health Care
- ZBAI Consumer Discretionary
- Exchange
- AEON Nasdaq
- ZBAI Nasdaq
- Market Cap
- AEON 13.5M
- ZBAI 11.3M
- IPO Year
- AEON N/A
- ZBAI N/A
- Fundamental
- Price
- AEON $0.91
- ZBAI $8.46
- Analyst Decision
- AEON Strong Buy
- ZBAI
- Analyst Count
- AEON 1
- ZBAI 0
- Target Price
- AEON $7.20
- ZBAI N/A
- AVG Volume (30 Days)
- AEON 391.7K
- ZBAI 90.2K
- Earning Date
- AEON 11-12-2025
- ZBAI 11-12-2025
- Dividend Yield
- AEON N/A
- ZBAI N/A
- EPS Growth
- AEON N/A
- ZBAI N/A
- EPS
- AEON N/A
- ZBAI N/A
- Revenue
- AEON N/A
- ZBAI $720,000.00
- Revenue This Year
- AEON N/A
- ZBAI N/A
- Revenue Next Year
- AEON N/A
- ZBAI N/A
- P/E Ratio
- AEON N/A
- ZBAI N/A
- Revenue Growth
- AEON N/A
- ZBAI 44.00
- 52 Week Low
- AEON $0.38
- ZBAI $4.83
- 52 Week High
- AEON $74.16
- ZBAI $45.00
- Technical
- Relative Strength Index (RSI)
- AEON 47.06
- ZBAI 50.05
- Support Level
- AEON $1.03
- ZBAI $7.54
- Resistance Level
- AEON $1.41
- ZBAI $8.96
- Average True Range (ATR)
- AEON 0.17
- ZBAI 0.76
- MACD
- AEON -0.01
- ZBAI -0.22
- Stochastic Oscillator
- AEON 15.83
- ZBAI 27.55
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About ZBAI ATIF Holdings Limited Ordinary Shares
ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.